Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zhenran Hu"'
Autor:
Huafu Li, Chunming Wang, Linxiang Lan, Wenhui Wu, Ian Evans, E. Josue Ruiz, Leping Yan, Zhijun Zhou, Joaquim M. Oliveira, Rui L. Reis, Zhenran Hu, Wei Chen, Axel Behrens, Yulong He, Changhua Zhang
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Oxaliplatin (OXA) resistance in the treatment of different types of cancer is an important and complex problem. The culture of tumor organoids derived from gastric cancer can help us to provide a deeper understanding of the underlying mechanisms that
Externí odkaz:
https://doaj.org/article/1a708a1fd2ea485db52e0b41bef62450
Publikováno v:
Journal of Hospitality and Tourism Management. 52:170-183
Publikováno v:
Highlights in Science, Engineering and Technology. 13:54-61
Formula one has always been the culmination of motorsport, but not necessarily the end of it. As the rapid development of technology, the vehicle attains more advanced equipment and the F1 lap’s times have improved year by year, meanwhile, the safe
Autor:
Huafu Li, Chunming Wang, Linxiang Lan, Leping Yan, Wuguo Li, Ian Evans, E. Josue Ruiz, Qiao Su, Guangying Zhao, Wenhui Wu, Haiyong Zhang, Zhijun Zhou, Zhenran Hu, Wei Chen, Joaquim M. Oliveira, Axel Behrens, Rui L. Reis, Changhua Zhang
Publikováno v:
Cellular and molecular life sciences : CMLS. 79(3)
Oxaliplatin is the first-line regime for advanced gastric cancer treatment, while its resistance is a major problem that leads to the failure of clinical treatments. Tumor cell heterogeneity has been considered as one of the main causes for drug resi